Business Context and Reporting Period
This Form 8-K is filed by Snap Interactive, Inc. (not Intelligent Protection Management Corp.) for the reporting period ending January 19, 2011. The filing reports the completion of a private placement offering of securities to accredited investors.
Key Financial Metrics
- Total Subscription Proceeds: $8,500,000
- Common Stock Issued: 4,250,000 shares at $2.00 per share
- Warrants Issued: 2,125,000 warrants (50% of purchased shares) exercisable at $2.50 per share
- Placement Agent Fee: 6% of aggregate purchase price (cash) plus 6% of future cash exercise proceeds
- Placement Agent Warrants: Warrants equal to 6% of purchased shares issued to Rodman & Renshaw, LLC
Note: This filing does not provide data on revenue, profit, operating cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the capital raise completed on January 19, 2011. The company entered into a definitive agreement with Rodman & Renshaw, LLC as the exclusive placement agent on January 7, 2011, and closed the transaction on January 19, 2011. This transaction significantly increased the company's cash position by $8.5 million and expanded its outstanding share count.
Guidance, Outlook, and Risks
- Registration Rights: The company agreed to file a registration statement within 30 days of the closing date to register the purchased shares and warrant shares.
- Liquidated Damages: If the registration statement is not filed or declared effective within specified timelines, the company must pay investors liquidated damages of 1.5% per month, capped at 9% of the investor's aggregate subscription amount.
- Exemption Status: The securities were sold under Regulation D Rule 506 and Section 4(2) of the Securities Act of 1933, meaning they are unregistered and subject to transfer restrictions until registered.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-issuance to assess dilution impact.
- Confirm the filing date of the registration statement to ensure compliance with the 30-day deadline and avoid liquidated damages.
- Review the company's use of proceeds to determine if the $8.5 million infusion addresses immediate liquidity needs or funds specific growth initiatives.
- Check for any subsequent filings regarding the effectiveness of the registration statement.